Clinical Trials for COVID-19 in Vermont

No COVID-19 trials are recruiting in Vermont today. New studies are posted regularly — try a neighbouring state, browse every COVID-19 trial nationwide, or see what else is recruiting in Vermont.

No COVID-19 trials are recruiting in Vermont right now

Recruitment opens and closes constantly, so this can change week to week. In the meantime, these searches are the usual next step — many studies reimburse travel for participants who live outside the immediate area.

COVID-19 clinical trials in Vermont: common questions

How many COVID-19 clinical trials are recruiting in Vermont?
No COVID-19 clinical trials are recruiting in Vermont right now. New studies are posted regularly, and you can browse COVID-19 trials in every other state or see all recruiting trials in Vermont instead.
Where are COVID-19 clinical trials located in Vermont?
No COVID-19 trials are recruiting in Vermont at the moment. Trials in neighbouring states are often still an option, and many studies reimburse travel costs for participants who live further away.
Do I need insurance to join a COVID-19 clinical trial in Vermont?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many COVID-19 trials in Vermont also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a COVID-19 clinical trial in Vermont?
Each study sets its own criteria based on age, COVID-19 diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.

Check Your Eligibility

Create a free profile and our AI will match you to COVID-19 trials near you in Vermont.

Get Matched — Free
No insurance required

COVID-19 trials study antiviral agents, monoclonal antibodies, long-COVID interventions, and vaccine platforms for prevention and treatment of SARS-CoV-2 infection.

All COVID-19 trials →